Parotidectomy Guidelines

Indications and Preoperative Evaluation

The American College of Surgeons recommends parotidectomy as the primary treatment for salivary gland malignancies, with the extent of surgery determined by tumor characteristics including size, grade, and location relative to critical neurovascular structures 1, 2
Salivary gland malignancies are indicated for parotidectomy as a primary treatment in resectable cases without distant metastases 1, 3
Fine needle aspiration biopsy (FNAB) with risk of malignancy (ROM) reporting using Milan System for Reporting Salivary Gland Cytopathology is recommended for preoperative evaluation 1, 4
Imaging studies are used to determine tumor extent and relationship to facial nerve 4
Assessment of facial nerve function is critical for surgical planning 2
Consideration of ancillary testing (IHC or molecular studies) on FNAB specimens is recommended to support diagnosis 4

For T1-T2 low-grade superficial tumors, partial superficial parotidectomy is appropriate, with complete excision and preservation of uninvolved parotid tissue 1, 2
For high-grade or advanced (T3-T4) tumors, at least superficial parotidectomy with consideration of total/subtotal parotidectomy is recommended due to risk of intraparotid nodal metastases 2
Preservation of facial nerve is recommended when preoperative function is intact and dissection plane can be created between tumor and nerve 2
Intraoperative frozen section may guide extent of resection but should not be sole basis for facial nerve sacrifice 1, 5
Indications for facial nerve resection include preoperative facial nerve weakness/paralysis and nerve branches encased or grossly involved by confirmed malignancy 2, 5

Complete excision with adequate free margins is aimed for, with narrow margins (≤5mm) showing excellent disease control in absence of adverse features for low/intermediate-grade tumors 1, 2, 3, 5
Margin status significantly affects overall survival 2
Facial nerve (CN VII) is the primary structure to identify and preserve when possible, with main trunk emerging from stylomastoid foramen and dividing into temporofacial and cervicofacial divisions 1, 2, 3, 5
External carotid artery and branches provide blood supply to parotid gland, including superficial temporal artery and maxillary artery 5

Intraoperative frozen section has 98.5% sensitivity and 99% specificity for detecting malignant parotid tumors 1, 5
Decisions that would result in major harm (such as facial nerve sacrifice) should not be based on indeterminate preoperative or intraoperative diagnoses alone 1, 5

For benign parotid tumors, a partial superficial parotidectomy is typically sufficient and can be safely performed as an outpatient procedure, as supported by the American Society of Clinical Oncology (ASCO) guidelines 6, 7
The American Society of Clinical Oncology (ASCO) guidelines support that for benign or low-grade tumors in the superficial lobe, partial superficial parotidectomy with preservation of the facial nerve is appropriate 6, 7, 8
Even for malignant tumors, ASCO guidelines recommend facial nerve preservation when a dissection plane can be created between the tumor and nerve 9, 10

The American College of Radiology recommends obtaining MRI with and without intravenous contrast for patients with suspected benign pleomorphic adenoma of the parotid gland when the lesion shows suspicious imaging features, demonstrates growth, or when detailed surgical planning is required; MRI provides superior soft‑tissue delineation of tumor extent, its relationship to the facial nerve, and potential deep‑lobe involvement. 11

Comprehensive facial nerve testing of all five branches (temporal, zygomatic, buccal, marginal mandibular, cervical) should be performed before any intervention; even subtle weakness may indicate nerve involvement by a malignant lesion. 12
Palpable cervical lymph nodes markedly increase suspicion for high‑grade parotid malignancy and should prompt further imaging and staging. 12
Trismus or limited jaw opening is a red‑flag sign suggesting deep invasion toward the masticator space. 13
Numbness in cranial nerve distribution raises concern for perineural invasion of the tumor. 13

MRI with and without intravenous contrast is the preferred modality for evaluating tumor size, deep‑lobe involvement, perineural spread, and the relationship to the facial nerve. 13
CT scanning may be used when MRI is contraindicated, but it provides inferior soft‑tissue detail compared with MRI. 13

Fine‑needle aspiration biopsy (FNAB) performed using the Milan System for Reporting Salivary Gland Cytopathology demonstrates a sensitivity of approximately 98 % and specificity of 99 % for detecting malignant parotid tumors. 12

When pre‑operative assessment shows facial nerve compromise, planned facial nerve resection should be considered as part of the oncologic surgery. 12

Avoid treating parotid pain as simple infection with antibiotics alone without imaging or tissue diagnosis, because this practice delays cancer detection. 14
Do not exclude malignancy solely because the mass appears cystic on clinical exam; malignant tumors can present with cystic components. [13][14]

Neck imaging should extend to the cervical region to assess for lymphadenopathy whenever malignancy is suspected, supporting accurate staging and treatment planning. [12][13]